Cargando…

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy

Detalles Bibliográficos
Autores principales: Pepe, Alessia, Meloni, Antonella, Rossi, Giuseppe, Dell'Amico, Maria Chiara, Spasiano, Anna, Capra, Marcello, Cianciulli, Paolo, Caruso, Vincenzo, Favilli, Brunella, Cracolici, Eliana, Maggio, Aurelio, Lombardi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106871/
http://dx.doi.org/10.1186/1532-429X-13-S1-O21
_version_ 1782205169276026880
author Pepe, Alessia
Meloni, Antonella
Rossi, Giuseppe
Dell'Amico, Maria Chiara
Spasiano, Anna
Capra, Marcello
Cianciulli, Paolo
Caruso, Vincenzo
Favilli, Brunella
Cracolici, Eliana
Maggio, Aurelio
Lombardi, Massimo
author_facet Pepe, Alessia
Meloni, Antonella
Rossi, Giuseppe
Dell'Amico, Maria Chiara
Spasiano, Anna
Capra, Marcello
Cianciulli, Paolo
Caruso, Vincenzo
Favilli, Brunella
Cracolici, Eliana
Maggio, Aurelio
Lombardi, Massimo
author_sort Pepe, Alessia
collection PubMed
description
format Online
Article
Text
id pubmed-3106871
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31068712011-06-03 A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy Pepe, Alessia Meloni, Antonella Rossi, Giuseppe Dell'Amico, Maria Chiara Spasiano, Anna Capra, Marcello Cianciulli, Paolo Caruso, Vincenzo Favilli, Brunella Cracolici, Eliana Maggio, Aurelio Lombardi, Massimo J Cardiovasc Magn Reson Oral Presentation BioMed Central 2011-02-02 /pmc/articles/PMC3106871/ http://dx.doi.org/10.1186/1532-429X-13-S1-O21 Text en Copyright ©2011 Pepe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Pepe, Alessia
Meloni, Antonella
Rossi, Giuseppe
Dell'Amico, Maria Chiara
Spasiano, Anna
Capra, Marcello
Cianciulli, Paolo
Caruso, Vincenzo
Favilli, Brunella
Cracolici, Eliana
Maggio, Aurelio
Lombardi, Massimo
A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
title A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
title_full A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
title_fullStr A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
title_full_unstemmed A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
title_short A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
title_sort t2* mri prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106871/
http://dx.doi.org/10.1186/1532-429X-13-S1-O21
work_keys_str_mv AT pepealessia at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT meloniantonella at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT rossigiuseppe at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT dellamicomariachiara at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT spasianoanna at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT capramarcello at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT cianciullipaolo at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT carusovincenzo at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT favillibrunella at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT cracolicieliana at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT maggioaurelio at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT lombardimassimo at2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT pepealessia t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT meloniantonella t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT rossigiuseppe t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT dellamicomariachiara t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT spasianoanna t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT capramarcello t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT cianciullipaolo t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT carusovincenzo t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT favillibrunella t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT cracolicieliana t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT maggioaurelio t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy
AT lombardimassimo t2mriprospectivesurveyonheartironinthalassemiamajorpatientstreatedwithdeferasiroxversusdeferiproneanddesferrioxamineinmonotherapy